01-15252. National Center for Complementary & Alternative Medicine; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel.Start Printed Page 32831

    Date: June 21, 2001.

    Time: 8:30 a.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Four Points Garden, 8400 Wisconsin Avenue, Bethesda, MD 20814.

    Contact Person: Martin H. Goldrosen, BS, MS, PhD., Chief, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd, Ste. 106, Bethesda, MD 20892-5475, (301) 496-4792, goldrosm@mail.nih.gov.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel.

    Date: June 28, 2001.

    Time: 2 p.m. to 3 p.m.

    Agenda: To review and evaluate grant applications.

    Place: 6707 Democracy Blvd., Bethesda, MD 20892, (Telephone Conference Call).

    Contact Person: Cecelia Maryland, Grants Technical Assistant, National Center for Complementary and Alternative Medicine, National Institutes of Health, Building 31, Room 5B50, Bethesda, MD 20892, (301) 480-2419.

    Start Signature

    Dated: June 11, 2001.

    Anna Snouffer,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 01-15252 Filed 6-15-01; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
6/21/2001
Published:
06/18/2001
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
01-15252
Dates:
June 21, 2001.
Pages:
32830-32831 (2 pages)
PDF File:
01-15252.pdf